Barone Francesca 4
4 · Candel Therapeutics, Inc. · Filed Mar 1, 2022
Insider Transaction Report
Form 4
Barone Francesca
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-28+110,000→ 110,000 totalExercise: $4.12Exp: 2032-02-28→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]This option is subject to time-based and performance-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following the Grant Date, subject to the Reporting Person's continued service on each such vesting date; provided, however, that one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $13.50 for any ten consecutive trading days prior to or as of December 31, 2022, and an additional one-third of the shares underlying this option shall only become exercisable if the average market price of the Issuer's common stock equals or exceeds $20.00 for any ten consecutive trading days prior to or as of December 31, 2022.